Cliff Asness’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$153K Buy
117,822
+1,142
+1% +$1.66K ﹤0.01% 3829
2026
Q1
$169K Buy
+116,680
New +$185K ﹤0.01% 3627
2022
Q1
Sell
-51,152
Closed -$228K 2290
2021
Q4
$228K Buy
51,152
+30,160
+144% +$148K ﹤0.01% 2051
2021
Q3
$138K Buy
20,992
+5,276
+34% +$50.6K ﹤0.01% 2187
2021
Q2
$252K Buy
+15,716
New +$217K ﹤0.01% 2090

Other funds holding STIM

Cliff Asness's STIM Position: Q2 2026 in Review

Cliff Asness increased its Neuronetics (STIM) stake by 0.98% in Q2 2026, buying an estimated $1.66K and bringing the position to 117,822 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #3829.

Cliff Asness first reported a position in STIM in Q2 2021 and has held it in 5 quarters since. The position peaked at $252K in Q2 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Cliff Asness held 117,822 shares of Neuronetics worth $153K as of Q2 2026.
  • Cliff Asness bought 1,142 Neuronetics shares in Q2 2026, an estimated $1.66K.
  • Neuronetics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3829 holding.
  • Cliff Asness first reported a position in Neuronetics in Q2 2021 and has held it in 5 quarters since.
  • Cliff Asness's Neuronetics position peaked at $252K in Q2 2021.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.